Newsroom
October 29, 2019
Transplant Genomics, Inc. Founders Awarded US Patent Covering Detection of “Silent” Sub-Clinical Rejection in Stable Kidney Transplant Recipients
Mansfield, MA, October 29, 2019 — MANSFIELD, Mass., Transplant Genomics, Inc. (“TGI”), a molecular diagnostics company committed to improving organ transplant…
October 11, 2019
Transplant Genomics, Inc. Confirms TruGraf® Will Receive Medicare Coverage Effective November 25, 2019
Mansfield, MA, October 11, 2019 — Transplant Genomics, Inc. (“TGI”), a molecular diagnostics company committed to improving organ transplant outcomes with non-invasive…
March 29, 2019
Medicare Issues Draft Local Coverage Determination (LCD) for Transplant Genomics’ TruGraf® Blood Test as Alternative to Surveillance Biopsies
Mansfield, MA, March 29, 2019 — Transplant Genomics Inc. (TGI) announces that Palmetto GBA has released a draft local coverage determination (LCD) for…
June 12, 2018
Studies Presented at American Transplant Congress Support Clinical Utility of TGI’s TruGraf® Tests for Management of Kidney Transplant Recipients
Mansfield, MA, June 12, 2018 — Transplant Genomics Inc. (TGI), a molecular diagnostics company committed to improving organ transplant outcomes, presented…
November 28, 2017
Clinical Utility Study Indicates Potential for TruGraf™ Test to Replace Surveillance Biopsies in Kidney Transplant Recipients with Stable Renal Function
Mansfield, MA, November 28, 2017 — Transplant Genomics Inc. (TGI), a molecular diagnostics company committed to improving organ transplant outcomes, has published…
October 24, 2017
Study Shows TruGraf Blood Test Enables Non-invasive Detection of Immune Quiescent Kidney Transplant Recipients
Mansfield, MA, October 24, 2017 — Transplant Genomics Inc. (TGI), a molecular diagnostics company committed to improving organ transplant outcomes, announces…
September 2, 2017
U.S. patent issues for gene expression profiles associated with chronic kidney allograft rejection, licensed exclusively to Transplant Genomics Inc.
Mansfield, MA, September, 2017 — The Scripps Research Institute (TSRI) has been issued a patent (US 9,752,191) covering gene expression profiles…
May 1, 2017
Genomic Signature for Predicting Acute Rejection in Liver Transplant Patients to be Presented at the American Transplant Congress
Chicago, IL, May 1, 2017— Dr. Josh Levitsky, Professor of Medicine (Gastroenterology, Hepatology) and Surgery (Organ Transplantation) at Northwestern University Feinberg School…
June 1, 2016
Transplant Genomics enters collaboration with Mayo Clinic
ROCHESTER, Minn. — Transplant Genomics Inc.® (TGI) is collaborating with the Mayo Clinic Center for Individualized Medicine to develop, validate and commercialize diagnostic tests…
May 2, 2016
Transplant Genomics Announces Immunosuppressive Clinical Trials Collaboration with Astellas Pharmaceuticals
Pleasanton, CA, and San Francisco, CA, May 2, 2016 — Transplant Genomics® today announced that they have signed a laboratory services agreement…